Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.
L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinson's disease (PD) that result from a progressive sensitization through repeated L-dopa exposures. The MPTP macaque model was used to study the proteome in dopamine-depleted striat...
Guardado en:
Autores principales: | Birger Scholz, Marcus Svensson, Henrik Alm, Karl Sköld, Maria Fälth, Kim Kultima, Céline Guigoni, Evelyne Doudnikoff, Qin Li, Alan R Crossman, Erwan Bezard, Per E Andrén |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/073d7fe810194b57805c4854dc0d06d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
por: Matthieu F. Bastide, et al.
Publicado: (2017) -
Striatal astrocytes act as a reservoir for L-DOPA.
por: Masato Asanuma, et al.
Publicado: (2014) -
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys.
por: Pierre-Olivier Fernagut, et al.
Publicado: (2010) -
Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.
por: Emanuela Santini, et al.
Publicado: (2010) -
Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and L-Dopa induced dyskinesia
por: Lauren Malave, et al.
Publicado: (2021)